IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VITA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.343
AS - Asia 12.475
EU - Europa 9.403
SA - Sud America 2.322
AF - Africa 289
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 37
Totale 47.918
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.893
SG - Singapore 4.508
CN - Cina 4.090
IT - Italia 2.485
UA - Ucraina 2.032
BR - Brasile 1.933
HK - Hong Kong 1.473
DE - Germania 1.101
FR - Francia 709
VN - Vietnam 615
GB - Regno Unito 585
FI - Finlandia 545
TR - Turchia 455
RU - Federazione Russa 450
IE - Irlanda 392
PL - Polonia 391
BD - Bangladesh 337
IN - India 329
CA - Canada 228
SE - Svezia 148
MX - Messico 139
AR - Argentina 138
CZ - Repubblica Ceca 107
NL - Olanda 106
ZA - Sudafrica 94
IQ - Iraq 93
JP - Giappone 90
ID - Indonesia 85
ES - Italia 67
EC - Ecuador 62
SA - Arabia Saudita 59
BE - Belgio 52
CO - Colombia 51
AT - Austria 49
AU - Australia 47
PK - Pakistan 45
UZ - Uzbekistan 44
NG - Nigeria 42
VE - Venezuela 41
LT - Lituania 32
PY - Paraguay 32
IR - Iran 31
MA - Marocco 30
EU - Europa 29
CH - Svizzera 28
EG - Egitto 25
KE - Kenya 23
CL - Cile 22
PE - Perù 21
PH - Filippine 20
NP - Nepal 18
TN - Tunisia 18
ET - Etiopia 17
IL - Israele 17
JO - Giordania 17
GR - Grecia 16
AE - Emirati Arabi Uniti 15
AL - Albania 15
AZ - Azerbaigian 15
JM - Giamaica 15
DZ - Algeria 14
MY - Malesia 14
PT - Portogallo 14
CR - Costa Rica 13
HU - Ungheria 13
KR - Corea 13
RO - Romania 12
HN - Honduras 11
UY - Uruguay 11
BG - Bulgaria 10
KG - Kirghizistan 10
KZ - Kazakistan 10
OM - Oman 9
PS - Palestinian Territory 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
PA - Panama 8
AM - Armenia 7
BY - Bielorussia 7
CI - Costa d'Avorio 7
LB - Libano 7
TT - Trinidad e Tobago 7
GT - Guatemala 6
SN - Senegal 6
TH - Thailandia 6
A1 - Anonimo 5
BH - Bahrain 5
MU - Mauritius 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
BB - Barbados 4
DK - Danimarca 4
LK - Sri Lanka 4
LV - Lettonia 4
RS - Serbia 4
SV - El Salvador 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
KW - Kuwait 3
MD - Moldavia 3
Totale 47.867
Salva come PNG Salva come JPEG
Città #
Singapore 2.441
Fairfield 2.179
Ashburn 1.981
Woodbridge 1.782
Jacksonville 1.541
Hong Kong 1.460
Houston 1.328
Chandler 1.119
The Dalles 957
Seattle 868
Cambridge 856
San Jose 842
Ann Arbor 807
Wilmington 785
Beijing 765
Princeton 720
New York 640
Nanjing 517
Los Angeles 407
Lauterbourg 400
Dublin 389
Warsaw 382
Brescia 379
Istanbul 374
Helsinki 331
Milan 311
Dallas 260
Council Bluffs 251
Munich 230
Ho Chi Minh City 217
Des Moines 187
Nanchang 185
Redondo Beach 174
São Paulo 171
Buffalo 167
Changsha 164
Moscow 164
Dearborn 154
Shenyang 138
Boardman 134
Rome 134
Tianjin 133
Lancaster 132
Chicago 127
Jinan 127
Hebei 124
Hanoi 121
Shanghai 115
San Diego 113
San Francisco 103
Santa Clara 101
Orem 96
London 88
Hangzhou 83
Jiaxing 80
Frankfurt am Main 79
Tokyo 76
Toronto 76
Brno 71
Brooklyn 68
Mexico City 63
Turku 63
Zhengzhou 62
Romola 60
Guangzhou 58
Rio de Janeiro 56
Belo Horizonte 54
Kunming 54
Montreal 53
Nuremberg 51
San Mateo 49
Johannesburg 48
Washington 48
Atlanta 46
Chennai 44
Denver 44
Tashkent 43
Stockholm 42
Abuja 40
Jakarta 40
Manchester 40
Turin 39
Brussels 37
Phoenix 37
Amsterdam 34
Augusta 34
Lanzhou 34
Norwalk 34
Salt Lake City 34
Verona 34
Mumbai 33
Ningbo 33
Boston 32
Charlotte 31
Haikou 31
Paris 31
Taizhou 31
Brasília 30
Orange 30
Porto Alegre 30
Totale 30.891
Salva come PNG Salva come JPEG
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 478
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 320
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 267
Il training cognitivo nei pazienti affetti da schizofrenia 244
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 237
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 232
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 219
Autism spectrum disorder and schizophrenia: Do they overlap? 212
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 209
Cognitive remediation in schizophrenia: current status and future perspectives. 201
Correlates of autistic traits among patients with borderline personality disorder 198
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 198
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 195
The patient journey project in Italian mental health services: results from a co-designed survey on clinical interventions and current barriers to improve the care of people living with schizophrenia 193
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 190
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 188
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 188
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 184
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 184
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 184
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 181
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 179
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 178
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 177
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 176
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 175
Cognitive remediation in schizophrenia. 175
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 175
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 175
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 173
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 172
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 172
Autistic symptoms predict social cognitive performance in patients with schizophrenia 170
A roadmap to disentangle the molecular etiology of schizophrenia 168
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 167
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 165
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 164
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 162
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 161
Factors Associated With Brain Heterogeneity in Schizophrenia 161
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 160
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 159
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 159
Adherence to antipsychotics in schizophrenia. 158
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 158
Cognitive remediation in the early course of schizophrenia: a critical review. 157
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 157
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 156
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 156
Translation and Validation of Italian Version of Index of Dental Anxiety and Fear (IDAF-4C+): A Cross-Sectional Study 156
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 155
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 155
A genome-wide search for schizophrenia susceptibility genes. 154
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 153
Brain structural effects of antidepressant treatment in major depression 153
Cognitive remediation in schizophrenia: a controlled study 152
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 152
Neuropsychological features in patients with severe mental disorders and risk of violence: A prospective multicenter study in Italy 152
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 151
Tools for measuring clinical effectiveness. 149
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 148
Additional Support for Schizophrenia Linkage on Chromosomes 6 and 8: A Multicenter Study 148
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 145
Age of onset in familial schizophrenia. 145
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 145
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 145
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 144
HLA-DR antigens in schizophrenia. 144
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 144
Season of birth and cerebral ventricular enlargement in schizophrenia 144
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 143
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 143
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials 143
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 142
Post-traumatic stress disorder and subthreshold post-traumatic stress disorder in recent male asylum seekers: An expected but overlooked “European” epidemic 142
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 142
Prevalence and Characteristics of Chemsex: A Cross-Sectional Observational Study 141
Developmental brain abnormalities in schizophrenia: contributions of genetic and perinatal factors. 141
Fertility and marital status in mood disorders: relationship with age at onset. 141
Cortical atrophy in schizophrenia: prevalence and associated features 140
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 140
Uso della PET e della SPECT in psichiatria 140
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 139
CT scan abnormalities and outcome of chronic schizophrenia 139
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 139
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 138
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 138
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 137
Carlo Lorenzo Cazzullo (1915-2010): father of Italian psychiatry 137
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 137
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services 137
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 137
Catatonia Spectrum: Validation of a Questionnaire Investigating Catatonia Spectrum 136
Magnetic resonance imaging findings in schizophrenia: relationships with language and thought disorders, symptomatology and cognitive performance. 136
Disturbi psichici perinatali:focus sulla depressione post partum. 135
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 135
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review 134
Early life events and affective disorder revisited. 134
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 134
Il rimedio cognitivo nelle psicosi: principi e metodi. 134
Totale 16.655
Salva come PNG Salva come JPEG
Categoria #
all - tutte 237.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021255 0 0 0 0 0 0 0 0 0 0 0 255
2021/20222.574 185 463 58 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20243.083 207 90 249 209 167 558 109 84 634 81 58 637
2024/20257.512 93 98 144 820 866 631 594 238 893 711 1.569 855
2025/202615.001 1.445 1.983 1.197 1.999 1.371 1.070 2.143 602 844 1.334 710 303
Totale 48.719